Exosomal proteins in prostate cancer progression: from mechanisms to diagnostic and therapeutic applications
Year: 2026
Type: article
Abstract: Prostate cancer (PCa) remains a leading cause of cancer death in men, and the limitations of prostate-specific antigen (PSA) testing continue to delay diagnosis and confound risk stratification. Exosomes, small extracellular vesicles that can be recovered non-invasively from blood and urine, provide a window onto tumour biology, and the proteins they carry are the most readily measurable of their cargoes for clinical assay development. This review summarises how exosomal proteins sustain four programmes that jointly drive PCa progression: Wnt/β-catenin-dependent metastasis, angiogenesis, immune evasion and the suppression of ferroptosis, the iron-dependent, lipid-peroxidation-driven cell death to which treatment-resistant PCa is vulnerable. Each protein is considered together with its cell of origin, carcinoma cells, cancer-associated fibroblasts or tumour-associated macrophages, because the same molecule can act differently depending on the cell that released it. Key examples include GIPC2, which engages the Wnt co-receptor Fzd7 to activate β-catenin signalling; PGAM1, which binds γ-actin in endothelial cells to promote angiogenesis; exosomal PD-1 and PD-L1, which respectively activate myeloid-derived suppressor cells and suppress CD8 + T cells; and FTH1P8 together with CAF-derived miR-432–5p, which blunt ferroptosis and sustain docetaxel and antiandrogen resistance. The review also covers the diagnostic value of urinary exosomal proteins such as PSMA and PSA, the difference between these protein markers and the RNA-based ExoDx EPI test, and the emerging advances, from GMP-compliant manufacturing and single-vesicle quantification to regulatory guidance, that are beginning to overcome the barriers of isolation heterogeneity, scalability, immunogenicity and regulation.
Authors: Yitao Wang, Yuhe Huang, Ziyi Song, Daojun Lv
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Keywords: prostate cancer, exosomal proteins, extracellular vesicles, tumor progression, Wnt/β-catenin signaling, metastasis, angiogenesis, immune evasion, ferroptosis, cancer-associated fibroblasts, tumour-associated macrophages, FZD7, phosphoglycerate mutase 1, PD-1, PD-L1, myeloid-derived suppressor cells, miR-432-5p, docetaxel resistance, androgen receptor resistance, urinary biomarkers, prostate-specific antigen, prostate-specific membrane antigen, exosome isolation, regulatory guidelines
Open Access status: gold
Estimated APC paid: $3,801
Award: G1500174561
OpenAlex ID: W7225905795
